Cardiol Therapeutics
(TSX) CRDL
Cardiol Therapeutics Financials at a Glance
Market Cap
CA$180.11M
Revenue (TTM)
CA$0.00
Net Income (TTM)
-CA$36.35M
EPS (TTM)
-CA$0.39
P/E Ratio
-4.13
Dividend
CA$0.00
Beta (Volatility)
1.72 (High)
Dividend
CA$0.00
Beta (Volatility)
1.72 (High)
Price
CA$1.58
Volume
11,715
Open
CA$1.58
Price
CA$1.58
Volume
11,715
Open
CA$1.58
Previous Close
CA$1.61
Daily Range
CA$1.56 - CA$1.58
52-Week Range
CA$1.23 - CA$2.33
Estimated Earnings Date
Aug 17, 2026
Dividend
CA$0.00
Beta (Volatility)
1.72 (High)
Price
CA$1.58
Volume
11,715
Open
CA$1.58
Previous Close
CA$1.61
Daily Range
CA$1.56 - CA$1.58
52-Week Range
CA$1.23 - CA$2.33
Estimated Earnings Date
Aug 17, 2026
CRDL News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Cardiol Therapeutics
Industry
Pharmaceuticals
Sector
Health CareEmployees
23
CEO
David G. Elsley, MBA
Website
www.cardiolrx.comHeadquarters
Oakville, ON L6H 0G5, CA
CRDL Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-174%
Return on Capital
-1%
Return on Assets
-1%
Earnings Yield
-24.21%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
CA$180.11M
Shares Outstanding
111.87M
Volume
11.71K
Avg. Volume
129.55K
Financials (TTM)
Gross Profit
CA$0.00
Operating Income
-CA$34.32M
EBITDA
-CA$34.21M
Operating Cash Flow
-CA$23.85M
Capital Expenditure
-CA$24.48K
Free Cash Flow
-CA$23.88M
Cash & ST Invst.
CA$21.42M
Total Debt
CA$125.52K
Cardiol Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
CA$0.00
N/A
Gross Profit
-CA$26.71K
-6.9%
Gross Margin
0.00%
N/A
Market Cap
CA$180.11M
N/A
Market Cap/Employee
CA$10.01M
N/A
Employees
18
N/A
Net Income
-CA$10.82M
-30.5%
EBITDA
-CA$9.68M
-15.2%
Quarterly Fundamentals
Net Cash
CA$27.56M
+19.1%
Accounts Receivable
CA$339.71K
-2.0%
Inventory
CA$0.00
N/A
Long Term Debt
CA$76.62K
-34.2%
Short Term Debt
CA$39.79K
-41.9%
Return on Assets
-1.16%
N/A
Return on Invested Capital
-1.47%
N/A
Free Cash Flow
-CA$7.57M
-5.6%
Operating Cash Flow
-CA$7.52M
-5.1%